Proto Labs, Inc. (NYSE:PRLB) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) has earned an average rating of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $53.3333.

Several research firms have recently commented on PRLB. Zacks Research raised Proto Labs from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, November 5th. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research report on Friday, August 1st. Cantor Fitzgerald upped their target price on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Benchmark raised their target price on shares of Proto Labs from $45.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, November 3rd. Finally, Wall Street Zen raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd.

Check Out Our Latest Research Report on Proto Labs

Proto Labs Trading Up 0.5%

PRLB opened at $51.03 on Friday. Proto Labs has a 1-year low of $29.58 and a 1-year high of $55.90. The stock has a market capitalization of $1.21 billion, a PE ratio of 85.05 and a beta of 1.23. The firm has a 50-day moving average price of $50.60 and a two-hundred day moving average price of $45.50.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings results on Friday, October 31st. The industrial products company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.39 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business had revenue of $135.37 million for the quarter, compared to analysts' expectations of $133.83 million. During the same period in the prior year, the firm earned $0.47 earnings per share. Proto Labs's revenue was up 8.0% compared to the same quarter last year. Proto Labs has set its Q4 2025 guidance at 0.300-0.380 EPS. On average, research analysts predict that Proto Labs will post 0.81 EPS for the current year.

Insider Buying and Selling at Proto Labs

In other news, insider Michael R. Kenison sold 3,048 shares of the firm's stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $50.17, for a total value of $152,918.16. Following the transaction, the insider directly owned 28,898 shares in the company, valued at $1,449,812.66. This trade represents a 9.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Proto Labs

Several hedge funds have recently added to or reduced their stakes in the stock. CWM LLC increased its stake in shares of Proto Labs by 50.4% in the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after acquiring an additional 617 shares during the last quarter. Victory Capital Management Inc. acquired a new position in Proto Labs during the first quarter valued at approximately $584,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Proto Labs in the first quarter valued at approximately $1,336,000. Mackenzie Financial Corp raised its holdings in Proto Labs by 7.9% in the first quarter. Mackenzie Financial Corp now owns 14,333 shares of the industrial products company's stock worth $502,000 after purchasing an additional 1,051 shares during the period. Finally, Federated Hermes Inc. boosted its position in shares of Proto Labs by 10.8% during the first quarter. Federated Hermes Inc. now owns 30,238 shares of the industrial products company's stock worth $1,060,000 after purchasing an additional 2,940 shares in the last quarter. Institutional investors and hedge funds own 84.54% of the company's stock.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.

Read More

• Five stocks we like better than Proto Labs
• Most Volatile Stocks, What Investors Need to Know
• Keysight Technologies' Surge: The Market Wakes Up to This AI Play
• Why Special Dividends Can be a Delightful Surprise for Income Investors
• Is American Express the Credit Stock For a K-Shaped Economy?
• What is a Secondary Public Offering? What Investors Need to Know
• Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here